Additionally, we observed significant expression of CLDN6, CES1, SOST, SPRR2A, MYBPH, CGB5, and KRT1 in the high-risk group, suggesting their potential involvement as cancer-promoting genes in BLCA development. The gene discussed is MYBPH; the disease is bladder transitional cell carcinoma.